Fungal prion

WikiDoc Resources for Fungal prion

Articles

Most recent articles on Fungal prion

Most cited articles on Fungal prion

Review articles on Fungal prion

Articles on Fungal prion in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fungal prion

Images of Fungal prion

Photos of Fungal prion

Podcasts & MP3s on Fungal prion

Videos on Fungal prion

Evidence Based Medicine

Cochrane Collaboration on Fungal prion

Bandolier on Fungal prion

TRIP on Fungal prion

Clinical Trials

Ongoing Trials on Fungal prion at Clinical Trials.gov

Trial results on Fungal prion

Clinical Trials on Fungal prion at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fungal prion

NICE Guidance on Fungal prion

NHS PRODIGY Guidance

FDA on Fungal prion

CDC on Fungal prion

Books

Books on Fungal prion

News

Fungal prion in the news

Be alerted to news on Fungal prion

News trends on Fungal prion

Commentary

Blogs on Fungal prion

Definitions

Definitions of Fungal prion

Patient Resources / Community

Patient resources on Fungal prion

Discussion groups on Fungal prion

Patient Handouts on Fungal prion

Directions to Hospitals Treating Fungal prion

Risk calculators and risk factors for Fungal prion

Healthcare Provider Resources

Symptoms of Fungal prion

Causes & Risk Factors for Fungal prion

Diagnostic studies for Fungal prion

Treatment of Fungal prion

Continuing Medical Education (CME)

CME Programs on Fungal prion

International

Fungal prion en Espanol

Fungal prion en Francais

Business

Fungal prion in the Marketplace

Patents on Fungal prion

Experimental / Informatics

List of terms related to Fungal prion

Fungal prions have been investigated, leading to a deeper understanding of disease-forming mammalian prions.

Prion-like proteins are found naturally in some plants and non-mammalian animals. Some of these are not associated with any disease state and may possibly even have a useful role[1]. Because of this, scientists reasoned that such proteins could give some sort of evolutionary advantage to their host. This was suggested to be the case in a species of fungus, Podospora anserina. Genetically compatible colonies of this fungus can merge together and share cellular contents such as nutrients and cytoplasm. A natural system of protective "incompatibility" proteins exists to prevent promiscuous sharing between unrelated colonies. One such protein, called HET-S, adopts a prion-like form in order to function properly [2]. The prion form of HET-S spreads rapidly throughout the cellular network of a colony and can convert the non-prion form of the protein to a prion state after compatible colonies have merged [3]. However, when an incompatible colony tries to merge with a prion-containing colony, the prion causes the "invader" cells to die, ensuring that only related colonies obtain the benefit of sharing resources.

## Contents

* 1 Sup35p & Ure2p
* 2 Classification
* 3 References
* 4 See also

## Sup35p & Ure2p

[edit | edit source]

In 1965, Brian Cox, a geneticist working with the yeast Saccharomyces cerevisiae, described a genetic trait (termed PSI+) with an unusual pattern of inheritance. The initial discovery of PSI+ was made in a strain auxotrophic for adenine due to a nonsense mutation [1] Despite many years of effort, Cox could not identify a conventional mutation that was responsible for the PSI+ trait.

In 1994, yeast geneticist Reed Wickner correctly hypothesized that PSI+ as well as another mysterious heritable trait, URE3, resulted from prion forms of certain normal cellular proteins [4]. It was soon noticed that heat shock proteins (which help other proteins fold properly) were intimately tied to the inheritance and transmission of PSI+ and many other yeast prions. Since then, researchers have unravelled how the proteins that code for PSI+ and URE3 can convert between prion and non-prion forms, as well as the consequences of having intracellular prions. When exposed to certain adverse conditions, PSI+ cells actually fare better than their prion-free siblings [5]; this finding suggests that, in some proteins, the ability to adopt a prion form may result from positive evolutionary selection [6]. It has been speculated that the ability to convert between prion infected and prion-free forms enables yeast to quickly and reversibly adapt in variable environments. Nevertheless, Wickner maintains that URE3 and PSI+ are diseases [7].

Further investigation found that PSI+ is the misfolded form of Sup35, which is an important factor for translation termination during protein synthesis [2]. It is believed that [PSI+] causes suppression of nonsense mutations by sequestering functional Sup35 in non-functional aggregates, thereby allowing stop codon readthrough. [PIN+], in turn, is the misfolded form of the protein Rnq1. However, the normal function of this protein is unknown to date. It is of note that for the induction of most variants of [PSI+], the presence of [PIN+] is required. Though reasons for this are poorly understood, it is suggested that [PIN+] aggregates may act as “seeds” for the polymerization of [PSI+] [3].

Two modified versions of Sup35 have been created that can induce PSI+ in the absence of [PIN+] when overexpressed. One version was created by digestion of the gene with BalI, which results in a protein consisting of only the M and N portions of Sup35 [4]. The other is a fusion of Sup35NM with HPR, a human membrane receptor protein.

Laboratories commonly identify [PSI+] by growth of a strain auxotrophic for adenine on media lacking adenine, similar to that used by Cox et al. These strains cannot synthesize adenine due to a nonsense mutation in one of the enzymes involved in biosynthetic pathway. When the strain is grown on yeast-extract/dextrose/peptone media (YPD), the blocked pathway results in buildup of a red-colored intermediate compound, which is exported from the cell due to its toxicity. Hence, color is an alternative method of identifying [PSI+] -- [PSI+] strains are white or pinkish in color, and [psi-] strains are red. A third method of identifying [PSI+] is by the presence of Sup35 in the pelleted fraction of cellular lysate.

## Classification

[edit | edit source]

Fungal Prions

Protein | Natural Host  | Normal Function  | Prion State  | Prion Phenotype
Ure2p  | Saccharomyces cerevisiae | Nitrogen catabolite repressor  | [URE3]  | Growth on poor nitrogen sources
Sup35p | Saccharomyces cerevisiae | Translation termination factor  | [PSI+]  | Increased levels of nonsense suppression
Rnq1p  | Saccharomyces cerevisiae | Protein template factor  | [RNQ+]  | Promotes aggregation of other prions
HET-S  | Podospora anserina | Regulates heterokaryon incompatibility  | [Het-s]  | Heterokaryon formation between incompatible strains

As of 2003, the following proteins in Saccharomyces cerevisiae had been identified or postulated as prions:

* Sup35p, forming the [PSI+] element;
* Ure2p, forming the [URE3] element;
* Rnq1p, forming the [RNQ+] element (also known as [PIN+])
* A fifth prion protein, forming the [ISP+] element remains to be identified.

## References

[edit | edit source]

1. ↑ Cox, B. S., M. F. Tuite and C. S. McLaughlin (1988). "The PSI+-Factor of Yeast - a Problem in Inheritance". Yeast 4, 159–178
2. ↑ Paushkin, S. V., V. V. Kushnirov, V. N. Smirnov and M. D. Ter-Avanesyan (1996). "Propagation of the yeast prion-like PSI+ determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor". EMBO (European Molecular Biology Organization) Journal 15, 3127–3134
3. ↑ Chernoff, Y. O. (2001). "Mutation processes at the protein level: Is Lamarck back?". Mutation Research 488, 39–64
4. ↑ Derkatch, I. L., M. E. Bradley, P. Zhou, Y. O. Chernoff and S. W. Liebman (1997). "Genetic and Environmental Factors Affecting the de novo Appearance of the [PSI+] Prion in Saccharomyces cerevisiae". Genetics 147 507–519

1. ^ A census of glutamine/asparagine-rich regions: Implications for their conserved function and the prediction of novel prions. PNAS USA. 2000 Oct 24; 97(22): 11910-5 Free text
2. ^ The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. PNAS USA. 1997 Sep 2; 94(18): 9773-8 Free text
3. ^ Amyloid aggregates of the HET-S prionprotein are infectious. PNAS USA. 2002 May 28; 99(11): 7402-7 Free text
4. ^ [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science. 1994 Apr 22; 264(5158): 566-9 Abstract
5. ^ A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature. 2000 Sep 28; 407(6803): 477-83 Abstract
6. ^ A small reservoir of disabled ORFs in the yeast genome and its implications for the dynamics of proteome evolution. J Mol Biol. 2002 Feb 22; 316(3): 409-19 Abstract
7. ^ Yeast prions [URE3] and [PSI+] are diseases. PNAS USA. 2005 July 26; 102(30): 10575-80 Free text

## See also

[edit | edit source]

* Prion
* Sup35p
* Epigenetics

Template:WS